Treatment of antibody-mediated rejection of kidney grafts with bortezomib and/or rituximab compared to standard regimen: experience of Slovene National Center-Reference-Cited by-同舟云学术

Treatment of antibody-mediated rejection of kidney grafts with bortezomib and/or rituximab compared to standard regimen: experience of Slovene National Center

Published:2017-07-01 Issue:S1 Volume:88 Page:91-96
ISSN:0301-0430
Container-title:Clinical Nephrology
language:en
Short-container-title:CN

Author:

Oblak Teja,LindiÄ Jelka,Gubenšek Jakob,Kveder Radoslav,Rigler Andreja Aleš,Škoberne Andrej,Haler Å½eljka VeÄeriÄ,Borštnar Špela,Avguštin Nuša,Ponikvar Rafael,Mlinšek Gregor,Ferluga Dušan,Kojc Nika,Godnov Uroš,KovaÄ Damjan

Publisher

Dustri-Verlgag Dr. Karl Feistle

Subject

Nephrology,General Medicine

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunomodulation par photo-chimiothérapie extracorporelle en transplantation rénale : preuves de concept, données cliniques et perspectives;Néphrologie & Thérapeutique;2023-10-01

2. Autologous Mesenchymal Stem Cells for Treatment of Chronic Active Antibody-Mediated Kidney Graft Rejection: Report of the Phase I/II Clinical Trial Case Series;Transplant International;2022-11-22

3. B cell modulation strategies in the improvement of transplantation outcomes;Molecular Immunology;2020-09

4. Diagnostic Performance of Donor-Derived Plasma Cell-Free DNA Fraction for Antibody-Mediated Rejection in Post Renal Transplant Recipients: A Prospective Observational Study;Frontiers in Immunology;2020-02-28

5. The Preliminary Results of Bortezomib Used as A Primary Treatment for An Early Acute Antibody-Mediated Rejection after Kidney Transplantation—A Single-Center Case Series;Journal of Clinical Medicine;2020-02-15